Medscape

Status Epilepticus-Related Deaths Nearly Double in US Adults

Mortality due to status epilepticus (SE) in the US nearly doubled from 1999 to 2020, increasing particularly among individuals aged 75 years or older and Black, a new retrospective study showed.
Nature

Status epilepticus of vascular origin results in high mortality

Research carried out in Marburg, Germany indicates that an episode of status epilepticus after stroke is associated with increased long-term mortality. Data from a prospective epidemiological study of ...
Medscape

Three Anticonvulsants Show Similar Efficacy in Status Epilepticus

Three anticonvulsant drugs used in benzodiazepine-refractory convulsive status epilepticus have been shown to have very similar levels of efficacy. Use of levetiracetam, fosphenytoin, and valproate ...
Business Wire

Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

PAOLI, Pa.--(BUSINESS WIRE)--Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved SESQUIENT (fosphenytoin sodium for injection) for the ...
Business Wire

Marinus Awarded BARDA Contract to Develop IV Ganaxolone for Treatment of Refractory Status Epilepticus Caused by Nerve Agent Exposure

RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today ...